ICU Review

pleiotropic beneficial SGLT2 inhibitor effects 1-Stimulation of renal erythropoietin (EPO) secretion,. As a result, SGLT2 inhibitors promote the formation of new red blood cells, leading to an increase in hematocrit levels. Recent studies have shown that SGLT2 inhibitors are effective in reducing mortality and in improving iron deficiency and anemia in individuals with HF and CKD. 2- sodium-glucose cotransporter 2 inhibitors slightly improve hepatic steatosis and fibrosis in adult patients with non-alcoholic fatty liver disease and Type 2 diabetes mellitus 3= The SGLT2 inhibitor empagliflozin is a promising new treatment option for chronic SIAD-induced hyponatremia, possibly improving neurocognitive function. 4-Added to tt of low EFHF; cardioprotective effect-improves edema 5-Renal protective effect in CKD

Noninvasive Ventilation for Preoxygenation during Emergency Intubation 2024

Home Oxygen Therapy for Adults with Chronic Lung Disease An Official American Thoracic Society Clinical Practice Guideline.pdf @HakimApps_Guideline

Diagnosis of Hypersensitivity Pneumonitis in Adults An Official ATS/JRS/ALAT Clinical Practice Guideline.pdf @HakimApps_Guideline

2020 ATS Diagnosis and Detection of Sarcoidosis.pdf @HakimApps_Guideline

American thoracic society (ATS) Respiratory Guidelines 👇👇

john-m-giacona-management-of-resistant-hypertension-an.pdf

📚The Refeeding Syndrome: a neglected but potentially serious condition for inpatients. A narrative review